131 results
Page 2 of 7
SC 14D9/A
ip03xi8
27 Oct 23
Tender offer solicitation (amended)
4:20pm
SC TO-T/A
sj21a
27 Oct 23
Third party tender offer statement (amended)
4:15pm
SC 14D9
rqgr2 wktqw4c3gyx87m
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
bei3m08vsyszhv fq41p
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
ukmfymd6
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
risai
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
43s1fje2lm yi1xb
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
7l79m cyiwa
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
cj4y6kps8r
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
xoi 0dl0tvd8
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.2
a4z7j5
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-2.1
jxmenzr
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
oim nmsthj
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
hwmkf2
3 Oct 23
Tender and Support Agreement
7:35am
8-K
6r2eslaf1iz
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.1
nu1ie v5bxo7y
14 Aug 23
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
7:21am
ARS
y8dh9y3
1 May 23
Annual report to shareholders
1:52pm